403 related articles for article (PubMed ID: 28250117)
1. The ND10 Component Promyelocytic Leukemia Protein Acts as an E3 Ligase for SUMOylation of the Major Immediate Early Protein IE1 of Human Cytomegalovirus.
Reuter N; Schilling EM; Scherer M; Müller R; Stamminger T
J Virol; 2017 May; 91(10):. PubMed ID: 28250117
[TBL] [Abstract][Full Text] [Related]
2. Proteasome-independent disruption of PML oncogenic domains (PODs), but not covalent modification by SUMO-1, is required for human cytomegalovirus immediate-early protein IE1 to inhibit PML-mediated transcriptional repression.
Xu Y; Ahn JH; Cheng M; apRhys CM; Chiou CJ; Zong J; Matunis MJ; Hayward GS
J Virol; 2001 Nov; 75(22):10683-95. PubMed ID: 11602710
[TBL] [Abstract][Full Text] [Related]
3. Evidence for a role of the cellular ND10 protein PML in mediating intrinsic immunity against human cytomegalovirus infections.
Tavalai N; Papior P; Rechter S; Leis M; Stamminger T
J Virol; 2006 Aug; 80(16):8006-18. PubMed ID: 16873257
[TBL] [Abstract][Full Text] [Related]
4. Ability of the human cytomegalovirus IE1 protein to modulate sumoylation of PML correlates with its functional activities in transcriptional regulation and infectivity in cultured fibroblast cells.
Lee HR; Kim DJ; Lee JM; Choi CY; Ahn BY; Hayward GS; Ahn JH
J Virol; 2004 Jun; 78(12):6527-42. PubMed ID: 15163746
[TBL] [Abstract][Full Text] [Related]
5. Recruitment of human cytomegalovirus immediate-early 2 protein onto parental viral genomes in association with ND10 in live-infected cells.
Sourvinos G; Tavalai N; Berndt A; Spandidos DA; Stamminger T
J Virol; 2007 Sep; 81(18):10123-36. PubMed ID: 17626080
[TBL] [Abstract][Full Text] [Related]
6. Covalent modification of the transactivator protein IE2-p86 of human cytomegalovirus by conjugation to the ubiquitin-homologous proteins SUMO-1 and hSMT3b.
Hofmann H; Flöss S; Stamminger T
J Virol; 2000 Mar; 74(6):2510-24. PubMed ID: 10684265
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of promyelocytic leukemia protein precludes the dispersal of ND10 structures and has no effect on accumulation of infectious herpes simplex virus 1 or its proteins.
Lopez P; Jacob RJ; Roizman B
J Virol; 2002 Sep; 76(18):9355-67. PubMed ID: 12186918
[TBL] [Abstract][Full Text] [Related]
8. Disruption of PML-associated nuclear bodies by IE1 correlates with efficient early stages of viral gene expression and DNA replication in human cytomegalovirus infection.
Ahn JH; Hayward GS
Virology; 2000 Aug; 274(1):39-55. PubMed ID: 10936087
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of interactions of human cytomegalovirus immediate-early IE2 regulatory protein with small ubiquitin-like modifiers and their conjugation enzyme Ubc9.
Ahn JH; Xu Y; Jang WJ; Matunis MJ; Hayward GS
J Virol; 2001 Apr; 75(8):3859-72. PubMed ID: 11264375
[TBL] [Abstract][Full Text] [Related]
10. Nuclear domain 10 components promyelocytic leukemia protein and hDaxx independently contribute to an intrinsic antiviral defense against human cytomegalovirus infection.
Tavalai N; Papior P; Rechter S; Stamminger T
J Virol; 2008 Jan; 82(1):126-37. PubMed ID: 17942542
[TBL] [Abstract][Full Text] [Related]
11. The major immediate-early proteins IE1 and IE2 of human cytomegalovirus colocalize with and disrupt PML-associated nuclear bodies at very early times in infected permissive cells.
Ahn JH; Hayward GS
J Virol; 1997 Jun; 71(6):4599-613. PubMed ID: 9151854
[TBL] [Abstract][Full Text] [Related]
12. SUMOylation of the human cytomegalovirus 72-kilodalton IE1 protein facilitates expression of the 86-kilodalton IE2 protein and promotes viral replication.
Nevels M; Brune W; Shenk T
J Virol; 2004 Jul; 78(14):7803-12. PubMed ID: 15220454
[TBL] [Abstract][Full Text] [Related]
13. Importance of covalent and noncovalent SUMO interactions with the major human cytomegalovirus transactivator IE2p86 for viral infection.
Berndt A; Hofmann-Winkler H; Tavalai N; Hahn G; Stamminger T
J Virol; 2009 Dec; 83(24):12881-94. PubMed ID: 19812159
[TBL] [Abstract][Full Text] [Related]
14. Revisiting promyelocytic leukemia protein targeting by human cytomegalovirus immediate-early protein 1.
Paulus C; Harwardt T; Walter B; Marxreiter A; Zenger M; Reuschel E; Nevels MM
PLoS Pathog; 2020 May; 16(5):e1008537. PubMed ID: 32365141
[TBL] [Abstract][Full Text] [Related]
15. Epstein-barr virus immediate-early protein BZLF1 is SUMO-1 modified and disrupts promyelocytic leukemia bodies.
Adamson AL; Kenney S
J Virol; 2001 Mar; 75(5):2388-99. PubMed ID: 11160742
[TBL] [Abstract][Full Text] [Related]
16. Differential relocation and stability of PML-body components during productive human cytomegalovirus infection: detailed characterization by live-cell imaging.
Dimitropoulou P; Caswell R; McSharry BP; Greaves RF; Spandidos DA; Wilkinson GW; Sourvinos G
Eur J Cell Biol; 2010 Oct; 89(10):757-68. PubMed ID: 20599291
[TBL] [Abstract][Full Text] [Related]
17. The human cytomegalovirus IE2 and UL112-113 proteins accumulate in viral DNA replication compartments that initiate from the periphery of promyelocytic leukemia protein-associated nuclear bodies (PODs or ND10).
Ahn JH; Jang WJ; Hayward GS
J Virol; 1999 Dec; 73(12):10458-71. PubMed ID: 10559364
[TBL] [Abstract][Full Text] [Related]
18. PML residue lysine 160 is required for the degradation of PML induced by herpes simplex virus type 1 regulatory protein ICP0.
Boutell C; Orr A; Everett RD
J Virol; 2003 Aug; 77(16):8686-94. PubMed ID: 12885887
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of SUMO-independent PML oligomerization by the human cytomegalovirus IE1 protein.
Kang H; Kim ET; Lee HR; Park JJ; Go YY; Choi CY; Ahn JH
J Gen Virol; 2006 Aug; 87(Pt 8):2181-2190. PubMed ID: 16847114
[TBL] [Abstract][Full Text] [Related]
20. PML isoforms I and II participate in PML-dependent restriction of HSV-1 replication.
Cuchet D; Sykes A; Nicolas A; Orr A; Murray J; Sirma H; Heeren J; Bartelt A; Everett RD
J Cell Sci; 2011 Jan; 124(Pt 2):280-91. PubMed ID: 21172801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
